BroadOak Capital Partners https://validator.w3.org/feed/docs/rss2.html Harvard Bioscience Announces Successful Completion of Debt Refinancing Tim Johnson Team Calvin Aubrey Investing BroadOak Capital Partners Adds More Than $200 Million of Permanent Capital to Supplement Investment Platform Trent Carrier Home Michael Caspani Codis Launches as Global CDMO for Commercial Spray Drying and Amorphous Solid Dispersions Codis Raises Growth Capital to Expand Commercial Manufacturing; Welcomes 1315 Capital Contact Portfolio Bill Snider Daniel Friedman Sale of BioServices business to Precision Bioservices Sale of Food Safety and GMO businesses to Romer Labs Sale of preclinical in-vivo imaging business to Bruker Exclusive placement agent for OpGen, Inc. BroadOak Partners provided financial advisory services to Quanta Biosciences Non-exclusive license agreement with QIAGEN BroadOak retained to provide ongoing financial advisory services SVT gains exclusive rights in China to ENMD-2076 through investment in EntreMed, Inc. Replacement and expansion of Cayman Chemical Company’s debt facilities Acquisition of Hyaluron, Inc. Acquisition of GlobalStem, Inc. Sale of in-vivo preclinical CRO services business to Taconic Farms, Inc. Sale of Alpha Innotech Corp. to Cell Biosciences, Inc. Collaboration and license agreement with Novartis Sale of non-core assets to Intrexon Corporation Sale of Assay Designs, Inc. to Enzo Biochem, Inc. Sale of Semrock Inc. to IDEX Corp Scientific Industries completes the divestiture of its Genie division to Troemner, a subsidiary of Mettler-Toledo Sale of Fluorescent Detection Products Business Waters Acquires Halo Labs, Expanding Biological Analysis Portfolio Particle Dynamics acquires EuroAPI UK Lars Hanan Acquisition of biodefense vaccines business from Avecia Biologics Limited Expertise and Industry Engagement Rubicon Founders Invests in Horizon Infusions About Sale of In Vitro Technologies, Inc to Celsis International Plc Acquisition of sales and marketing rights to EpiPen in Canada from Allerex Laboratory Acquisition of Control Delivery Systems Sale of the company to Werfen Transactions Advisory Pluristyx Completes Investment Round to Expand Product Portfolio and Commercial Operations Battery Ventures Completes Take-Private Transaction with Enzo Biochem Matt McFarland